DAWN · Day One Biopharmaceuticals, Inc.

$21.53 +0.00 (+0.00%) At close · Apr 24

Market Cap

$2.22B

103.33M

Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.

Fiscal 2024

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Jeremy Bender	CEO	$680,000	—	$2,700,280	$2,664,697	$501,800	$13,800	$6,560,577
Charles York II	CFO	$541,000	—	$1,530,640	$1,511,240	$299,400	$13,800	$3,896,080
Samuel Blackman	Co-Founder and Head of R&D	$527,000	—	$1,400,680	$1,381,724	$291,700	$13,800	$3,614,904
Adam Dubow	General Counsel	$455,000	—	$851,960	$840,954	$223,900	$13,800	$2,385,614

Fiscal 2023

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Jeremy Bender	CEO	$647,000	—	$1,779,160	$4,086,399	$388,200	$13,200	$6,913,959
Charles York II	CFO	$515,000	—	$842,760	$1,943,333	$231,800	$13,200	$3,546,093
Adam Dubow	General Counsel	$425,000	—	$655,480	$1,509,573	$170,000	$13,200	$2,773,253
Samuel Blackman	Co-Founder and Head of R&D	$500,000	—	$538,430	$1,206,462	$227,300	$13,200	$2,485,392

Fiscal 2022

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Jeremy Bender	CEO	$610,000	—	$812,820	$3,361,436	$290,000	$12,200	$5,086,456
Charles York II	CFO	$495,000	—	$313,720	$1,278,531	$220,000	$12,200	$2,319,451
Samuel Blackman	Co-Founder and Head of R&D	$470,000	—	$270,940	$1,143,057	$181,000	$12,200	$2,077,197

Fiscal 2021

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Jeremy Bender	CEO	$523,021	—	$5,168,061	$13,756,228	$313,800	—	$19,761,110
Charles York II	CFO	$396,042	$100,000	$2,534,266	$4,670,232	$218,300	—	$7,918,840
Samuel Blackman	Co-Founder and Head of R&D	$422,568	—	$493,000	$1,815,322	$205,000	—	$2,935,890

Fiscal 2020

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Jeremy Bender	CEO	$141,667	—	$2,555,158	—	$56,356	—	$2,753,181
Samuel Blackman	Co-Founder and Head of R&D	$367,000	—	—	—	$110,100	—	$477,100

Key facts CIK 1845337 CUSIP 23954D109 13F (30d) 1 filings 1 filers Visit website Investor relations